Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Charge‐Reversed Lipid Nanoparticles Enable Encapsulation of Pt <sub>2</sub> L <sub>4</sub> Nanocages for In vivo Anti‐Cancer Treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41392‐021‐00572‐w
10.1038/s41392‐021‐00572‐w · External reference
10.1016/s0140‐6736(20)30164‐1
10.1016/s0140‐6736(20)30164‐1 · External reference
10.1016/j.mtbio.2023.100605
10.1016/j.mtbio.2023.100605 · External reference
10.3390/pharmaceutics15061648
10.3390/pharmaceutics15061648 · External reference
10.1038/s41392‐022‐00947‐7
10.1038/s41392‐022‐00947‐7 · External reference
10.1021/acs.accounts.3c00769
10.1021/acs.accounts.3c00769 · External reference
10.1016/j.cell.2020.02.001
10.1016/j.cell.2020.02.001 · External reference
Current Approaches in Smart Nano‐Inspired Drug Delivery: A Narrative Review
10.1002/hsr2.2065 · 2024 · External reference
10.3389/fmolb.2020.00193
10.3389/fmolb.2020.00193 · External reference
10.1021/acs.nanolett.0c00495
10.1021/acs.nanolett.0c00495 · External reference
10.1016/j.jconrel.2022.12.028
10.1016/j.jconrel.2022.12.028 · External reference
10.1016/j.addr.2020.06.005
10.1016/j.addr.2020.06.005 · External reference
10.1038/s41467‐023‐41946‐8
10.1038/s41467‐023‐41946‐8 · External reference
10.1016/j.biomaterials.2014.04.023
10.1016/j.biomaterials.2014.04.023 · External reference
10.3389/fonc.2023.1154318
10.3389/fonc.2023.1154318 · External reference
10.1038/nbt.2612
10.1038/nbt.2612 · External reference
10.1039/c9nr02004g
10.1039/c9nr02004g · External reference
Synthesis and Characterization of Hybrid Lipid Nanoparticles Containing Gold Nanoparticles and a Weak Base Drug
10.1021/acs.langmuir.2c01221 · 2022 · External reference
10.1016/j.apsb.2022.04.013
10.1016/j.apsb.2022.04.013 · External reference
10.1016/j.addr.2024.115446
10.1016/j.addr.2024.115446 · External reference
10.1038/s41578‐021‐00358‐0
10.1038/s41578‐021‐00358‐0 · External reference
10.3109/08982104.2012.742538
10.3109/08982104.2012.742538 · External reference
10.1038/srep17220
10.1038/srep17220 · External reference
10.1016/j.xphs.2020.02.010
10.1016/j.xphs.2020.02.010 · External reference
Gadolinium Labelled Nanoliposomes as the Platform for MRI Theranostics: In Vitro Safety Study in Liver Cells and Macrophages
10.1038/s41598-020-60284-z · 2020 · External reference
10.1002/mrm.1910110211
10.1002/mrm.1910110211 · External reference
10.1002/adma.202312026
10.1002/adma.202312026 · External reference
10.1039/d3sc01086d
10.1039/d3sc01086d · External reference
10.1038/s41467‐024‐55137‐6
10.1038/s41467‐024‐55137‐6 · External reference
10.1073/pnas.1306529110
10.1073/pnas.1306529110 · External reference
10.1038/mtna.2014.61
10.1038/mtna.2014.61 · External reference
10.1038/s41563‐020‐00886‐0
10.1038/s41563‐020‐00886‐0 · External reference
10.1021/acsnano.3c09028
10.1021/acsnano.3c09028 · External reference
10.1016/j.bbalip.2018.07.012
10.1016/j.bbalip.2018.07.012 · External reference
10.1080/20415990.2025.2506977
10.1080/20415990.2025.2506977 · External reference
10.1021/acsnano.7b06995
10.1021/acsnano.7b06995 · External reference
10.1016/j.colsurfb.2015.10.029
10.1016/j.colsurfb.2015.10.029 · External reference
10.3390/pharmaceutics16121521
10.3390/pharmaceutics16121521 · External reference
10.1038/s41467‐025‐58523‐w
10.1038/s41467‐025‐58523‐w · External reference
10.1016/j.jconrel.2024.07.046
10.1016/j.jconrel.2024.07.046 · External reference
10.1002/adma.202401445
10.1002/adma.202401445 · External reference
10.1002/adma.202313791
10.1002/adma.202313791 · External reference
Why do Lipid Nanoparticles Target the Liver? Understanding of Biodistribution and Liver‐Specific Tropism
10.1016/j.omtm.2025.101436 · 2025 · External reference
10.1016/j.omtm.2023.06.005
10.1016/j.omtm.2023.06.005 · External reference
10.1016/j.jconrel.2024.05.034
10.1016/j.jconrel.2024.05.034 · External reference
10.1002/adma.202201095
10.1002/adma.202201095 · External reference
10.1016/j.bmcl.2015.03.016
10.1016/j.bmcl.2015.03.016 · External reference
10.3390/ph14070625
10.3390/ph14070625 · External reference
10.1002/adhm.201901489
10.1002/adhm.201901489 · External reference
10.3390/cancers14092238
10.3390/cancers14092238 · External reference
Ewing Sarcoma Inhibition by Disruption of EWSR1–FLI1 Transcriptional Activity and Reactivation of P53
10.1002/path.4378 · 2014 · External reference
10.1016/j.cell.2019.04.004
10.1016/j.cell.2019.04.004 · External reference
The Zebrafish as a Tool to Cancer Drug Discovery
2015 · External reference
10.1073/pnas.1618389114
10.1073/pnas.1618389114 · External reference
10.1007/s10456‐006‐9040‐2
10.1007/s10456‐006‐9040‐2 · External reference
10.1186/1471‐2407‐9‐128
10.1186/1471‐2407‐9‐128 · External reference
10.1242/dmm.015784
10.1242/dmm.015784 · External reference
10.1158/0008‐5472.can‐06‐4268
10.1158/0008‐5472.can‐06‐4268 · External reference
10.1242/jcs.069443
10.1242/jcs.069443 · External reference
10.1021/acsnano.4c14625
10.1021/acsnano.4c14625 · External reference
10.1016/j.biomaterials.2017.11.040
10.1016/j.biomaterials.2017.11.040 · External reference
10.1039/d2bm01846b
10.1039/d2bm01846b · External reference
10.1038/mtna.2013.66
10.1038/mtna.2013.66 · External reference
10.1021/acs.bioconjchem.3c00174
10.1021/acs.bioconjchem.3c00174 · External reference
10.1016/j.jconrel.2025.114598
10.1016/j.jconrel.2025.114598 · External reference
10.1038/s41565‐020‐0669‐6
10.1038/s41565‐020‐0669‐6 · External reference
